News from UNITAID
The Medicines Patent Pool and Abbvie Sign Licensing Agreement to Increase Access to Crucial HIV treatments Throughout Africa
Geneva, 18 December 2015 — The Medicines Patent Pool (MPP) today announced a new licensing agreement with AbbVie, a global biopharmaceutical company, that seeks to address future demands for HIV treatment Lopinavir/Ritonavir (LPV/r) in South Africa and across Africa....
UNITAID Reviews Landscape in Diagnostics Technology for HIV
UNITAID today released its 2015 HIV/AIDS Diagnostics Technology Landscape that summarizes the latest products and technologies to detect, stage and monitor HIV infection. The Landscape covers technologies including instruments for laboratories, multi-purpose platforms...